FAVHIV .: A composition for use in a method for prevention or treatment of human immunodefitiency virus infections (Q2906304): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 85.01 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
| Property / budget | Property / budget | ||||||||||
| 6,463.26 Euro
| ||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||
| 5,493.77 Euro
| ||||||||||
| Property / priority axis | |||||||||||
| Property / priority axis: Strengthening research, technological development and innovation (OT1) / rank | |||||||||||
Normal rank | |||||||||||
| Property / co-financing rate | |||||||||||
85.0 percent
| |||||||||||
| Property / co-financing rate: 85.0 percent / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 01:32, 5 November 2022
Project Q2906304 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FAVHIV .: A composition for use in a method for prevention or treatment of human immunodefitiency virus infections |
Project Q2906304 in Portugal |
Statements
5,493.77 Euro
0 references
6,463.26 Euro
0 references
85.0 percent
0 references
7 November 2016
0 references
6 November 2017
0 references
INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA
0 references
Q2993187 (Deleted Item)
0 references
41°8'58.02"N, 8°36'38.84"W
0 references
Porto
0 references
Identifiers
POCI-01-0145-FEDER-026103
0 references